Payer mix shift impacting margins
Increase in scheme business (CGHS/ECHS) and higher share of lower-margin specialties (ortho, onco) compressed hospital EBITDA margins by ~2% in Q1.
FORTIS / Q1-FY25 / risks
Keep the risk register visible.
Fortis Healthcare · Material risks, their source context, and severity in the latest available quarter.
Research layer active
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
Material risks this quarter
medium
Agilus underperformance and brand transition drag
Diagnostics revenue remained flat YoY, with margins declining due to rebranding costs and government provisions; recovery may take longer than expected.
Legal costs from Daiichi dispute to persist
Legal costs related to the Daiichi litigation are expected to remain high this year, with potential appeals adding uncertainty.
Geopolitical risks impacting medical travel
Recent developments in Bangladesh and Israel may affect international patient flows, though management expects no material impact.